An update on the use of tumor necrosis factor alpha inhibitors in the treatment of ankylosing spondylitis.
about
Role of Diffusion-weighted and Contrast-enhanced Magnetic Resonance Imaging in Differentiating Activity of Ankylosing SpondylitisSafety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: A meta-analysis.Golimumab: A Review in Inflammatory Arthritis.Dissecting the Underlying Pharmaceutical Mechanism of Chinese Traditional Medicine Yun-Pi-Yi-Shen-Tong-Du-Tang Acting on Ankylosing Spondylitis through Systems Biology Approaches.Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritis.Evaluation of the comorbidity burden in patients with ankylosing spondylitis treated with tumour necrosis factor inhibitors using a large administrative claims data set.
P2860
An update on the use of tumor necrosis factor alpha inhibitors in the treatment of ankylosing spondylitis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
An update on the use of tumor ...... ent of ankylosing spondylitis.
@en
type
label
An update on the use of tumor ...... ent of ankylosing spondylitis.
@en
prefLabel
An update on the use of tumor ...... ent of ankylosing spondylitis.
@en
P2860
P1476
An update on the use of tumor ...... ent of ankylosing spondylitis.
@en
P2093
Mohammed S Osman
Walter P Maksymowych
P2860
P304
P356
10.1080/1744666X.2016.1218761
P577
2016-08-01T00:00:00Z